Our favorite Carlsbadistan-based life sciences company Life Technologies Corp. (we’re shareholders) reported second quarter numbers yesterday and while profits were down versus last year, the company beat analyst’s estimates, according to a story on TradingMarkets.com.
The . . . company reported GAAP net income for the second quarter of $38.9 million or $0.22 per share, compared to $46.9 million or $0.48 per share for the year-ago quarter. . . The company, which makes tools used to identify the H1N1 strain of influenza, also lifted its financial guidance for the rest of the year in an earnings report released after the market closed Tuesday.
And thanks to that the stock was up $3.14 a share this morning, or nearly 8 percent. Thanks, Swine Flu.
[Link: Trading Markets and The Street.com]
RSS Feed-Posts
{ 0 comments… add one now }